Inventor · disambiguated record
Michael Parnham
Also filed as: PARNHAM MICHAEL · PARNHAM MICHAEL J · PARNHAM MICHAEL JOHN
16 granted patents·7 pending applications·76 citations·filing 1983–2021
91Inventor score
Top patents by PatentIndex Score
23 records- 0181US4757063AProcess for the treatment of diseases caused by oxidative stressNATTERMANN A & CIE·Filed 1987·Granted Jul 12, 1988·30 cites·1 claims
- 0281US4618669AS-(carbamoyl-phenylselenyl) derivatives of glutathione and of aminomercaptocarboxylic acidsNATTERMANN A & CIE·Filed 1985·Granted Oct 21, 1986·19 cites·3 claims
- 0377US11679142B2B7-H1 fusion polypeptides for treating and preventing organ failureFRAUNHOFER GES FORSCHUNG·Filed 2020·Granted Jun 20, 2023·1 cites·14 claims
- 0477US10413605B2Combination therapy for the treatment of autoimmune diseasesFRAUNHOFER GES FORSCHUNG·Filed 2014·Granted Sep 17, 2019·4 cites·10 claims
- 0572US10632174B2B7-H1 fusion polypeptides for treating and preventing organ failureFRAUNHOFER GES FORSCHUNG·Filed 2016·Granted Apr 28, 2020·1 cites·12 claims
- 0668US2022257755A1Combination therapy for the treatment of autoimmune diseasesFRAUNHOFER GES FORSCHUNG·Filed 2021·Application pending·0 cites
- 0763US10093628B2Competitive PPAR-gamma antagonistsFRAUNHOFER GES FORSCHUNG·Filed 2015·Granted Oct 9, 2018·2 cites·15 claims
- 0862US11944613B2CYP2J2 antagonists in the treatment of painFRAUNHOFER GES FORSCHUNG·Filed 2019·Granted Apr 2, 2024·0 cites·6 claims
- 0959US4910313ADiselenobis benzoic acid amides of primary heterocyclic amines, process for producing the same and process for the treatment of certain diseases in humansNATTERMANN A & CIE·Filed 1987·Granted Mar 20, 1990·9 cites·1 claims
- 1055US4565659ASubstituted aminoalkanol phospholipidsNATTERMANN A & CIE·Filed 1983·Granted Jan 21, 1986·4 cites·5 claims
- 1154US2020277349A1N-terminally truncated interleukin-38FRAUNHOFER GES FORSCHUNG·Filed 2020·Application pending·0 cites
- 1253US2019351056A1Combination therapy for the treatment of autoimmune diseasesFRAUNHOFER GES FORSCHUNG·Filed 2019·Application pending·0 cites
- 1347US2023174619A1PD-L1 variants with improved affinity towards PD-1FRAUNHOFER GES FORSCHUNG·Filed 2021·Application pending·0 cites
- 1444US11427630B2Antibody inhibitors of IL-38 and methods of use thereof for treating or reducing the likelihood of cancer in a subjectFRAUNHOFER GES FORSCHUNG·Filed 2018·Granted Aug 30, 2022·0 cites·13 claims
- 1542US10618946B2N-terminally truncated interleukin-38FRAUNHOFER GES FORSCHUNG·Filed 2015·Granted Apr 14, 2020·0 cites·1 claims
- 1642US2017266169A1Cyp2j2 antagonists in the treatment of painFRAUNHOFER GES FORSCHUNG·Filed 2015·Application pending·0 cites
- 1741US4705802AOmega-aryl-alkylthienyl-compounds and process for the treatment of chronically inflammatory processes in humansNATTERMANN A & CIE·Filed 1985·Granted Nov 10, 1987·3 cites·3 claims
- 1841US4599205A1-O-alkyl-3-amino-propan-1.2-diol-2-O-phospholipidsNATTERMANN A & CIE·Filed 1984·Granted Jul 8, 1986·2 cites·2 claims
- 1937US10953103B2Composition comprising a biocompatible and biodegradable polymer, nanocarriers and a drug and methods of making and using the sameFRAUNHOFER GES FORSCHUNG·Filed 2016·Granted Mar 23, 2021·0 cites·11 claims
- 2036US2020200775A1Oxidized lipids as biomarkers for neuropathic painFRAUNHOFER GES FORSCHUNG·Filed 2017·Application pending·0 cites
- 2131US5126357AAnti-inflammatory picolyselenobenzamides and salts thereofNATTERMANN A & CIE·Filed 1990·Granted Jun 30, 1992·0 cites·7 claims
- 2231US4600722A3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazolines and a process for the treatment of inflammatory or allergic processes in humansNATTERMANN A & CIE·Filed 1985·Granted Jul 15, 1986·1 cites·5 claims
- 2329US2005054587A1Novel therapeutic indication of azithromycin for treatment of non-infective inflamatory diseasesFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Parnham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →